5-fluorouracil plus levamisole with or without 6-S-leucovorin as adjuvant treatment of resected colon cancer

被引：0
|
作者：
机构：
来源：
ADJUVANT THERAPY OF CANCER VIII | 1997年 / 8卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：193 / 197
页数：5
相关论文
共 50 条
  • [1] Adjuvant chemotherapy in stage III colon cancer with 5-fluorouracil and levamisole versus 5-fluorouracil and leucovorin
    Dencausse, Y
    Hartung, G
    Sturm, J
    Kopp-Schneider, A
    Hagmüller, E
    Wojatschek, C
    Lindemann, H
    Fritze, D
    Queisser, W
    ONKOLOGIE, 2002, 25 (05): : 426 - 430
  • [2] 5-fluorouracil (FU) and levamisole (LEVA) versus FU, leva and 6-S-leucovorin (6-S-LV): An italian intergroup study of adjuvant therapy for resected colon cancer (B2-C)
    不详
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 720 - 720
  • [3] SULINDAC PLUS 5-FLUOROURACIL AND LEVAMISOLE - POTENTIAL ADJUVANT TREATMENT FOR COLON-CANCER
    SINICROPE, FA
    PAZDUR, R
    LEVIN, B
    GASTROENTEROLOGY, 1995, 108 (04) : A539 - A539
  • [4] ADJUVANT 5-FLUOROURACIL PLUS LEVAMISOLE IN COLON-CANCER - THE PLOT THICKENS
    CASSIDY, J
    BRITISH JOURNAL OF CANCER, 1994, 69 (06) : 986 - 987
  • [5] LEUCOVORIN PLUS 5-FLUOROURACIL - AN EFFECTIVE TREATMENT FOR METASTATIC COLON CANCER
    LAUFMAN, LR
    KRZECZOWSKI, KA
    ROACH, R
    SEGAL, M
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (09) : 1394 - 1400
  • [6] Combined intravenous and intraperitoneal chemotherapy with fluorouracil plus leucovorin vs fluorouracil plus levamisole for adjuvant therapy of resected colon carcinoma
    Scheithauer, W
    Kornek, GV
    Marczell, A
    Karner, J
    Salem, G
    Greiner, R
    Burger, D
    Stöger, F
    Ritschel, J
    Kovats, E
    Vischer, HM
    Schneeweiss, B
    Depisch, D
    BRITISH JOURNAL OF CANCER, 1998, 77 (08) : 1349 - 1354
  • [7] LEVAMISOLE AND 5-FLUOROURACIL THERAPY FOR RESECTED COLON CANCER - A NEW INDICATION
    SKILLINGS, JR
    LEVINE, M
    RAYNER, HL
    EISENHAUER, E
    ERLICHMAN, C
    GERMOND, C
    KERR, I
    LOFTERS, W
    MAROUN, J
    YOSHIDA, S
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1991, 144 (03) : 297 - 301
  • [8] Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer
    A Sobrero
    G Frassineti
    A Falcone
    L Dogliotti
    R Rosso
    F D Costanzo
    P Bruzzi
    British Journal of Cancer, 2005, 92 : 24 - 29
  • [9] Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer
    Sobrero, A
    Frassineti, G
    Falcone, A
    Dogliotti, L
    Rosso, R
    Costanzo, FD
    Bruzzi, P
    BRITISH JOURNAL OF CANCER, 2005, 92 (01) : 24 - 29
  • [10] The role of levamisole in the adjuvant treatment of stage III colon cancer patients: A randomized trial of 5-fluorouracil and levamisole versus 5-fluorouracil alone
    Cascinu, S
    Catalano, V
    Piga, A
    Mattioli, R
    Marcellini, M
    Pancotti, A
    Bascioni, R
    Torresi, U
    Silva, RR
    Pieroni, V
    Giorgi, F
    Catalano, G
    Cellerino, R
    CANCER INVESTIGATION, 2003, 21 (05) : 701 - 707
12345